The online version of this article (doi:10.1186/1477-7819-10-3) contains supplementary material, which is available to authorized users.
Yue Chen, Gang Wang contributed equally to this work.
The authors declare that they have no competing interests.
YC carried out the experiments, analyzed the data and drafted the manuscript. GW conducted the experiments and participated in the design of the study. DK, ZZ, KY and RL assisted with experiments and help to draft the manuscript. WZ conceived of the study, and participated in its design. YX conceived of the study, participated in its design and revised the manuscript. All authors read and approved the final manuscript.
One of the most frequently used and efficient suicide gene therapies for prostate cancer is HSV-TK/GCV system, but its application has been limited due to lack of favorable gene vector and the reduction of "bystander effect". We investigated the effect of a novel combination of HSV-TK/GCV fused with Cx43 and gemcitabine using non-viral vector generation 5 polyamidoamine dendrimers (G5-PAMAM-D) on PC-3 cells.
RT-PCR and Western blot were used to detect TK and Cx43 expression. Cell viability and proliferation were measured by using MTT assay. Cell apoptosis was detected with double-staining of Annexin V-FITC and propidium iodide (PI) by flow cytometry. Nude mice models were established to evaluate the therapeutic effect in vivo.
G5-PAMAM-D efficiently delivered recombinant plasmids into PC-3 cells and HSV-TK and Cx43 could be expressed successfully. With gemcitabine, G5-PAMAM-D mediated HSV-TK and Cx43 expression effectively inhibited prostate cancer PC-3 cell proliferation, leading to more cellular apoptosis and inhibiting PC-3 tumor growth in nude mice models.
This study illustrates that this new suicide gene system mediated by G5-PAMAM-D is effective in decreasing PC-3 cell proliferation and inducing cell apoptosis, and inhibiting tumor growth in vivo. In a word, our study could provide a potential approach for gene therapy of prostate cancer.
Authors’ original file for figure 112957_2011_938_MOESM1_ESM.tiff
Authors’ original file for figure 212957_2011_938_MOESM2_ESM.tiff
Authors’ original file for figure 312957_2011_938_MOESM3_ESM.tiff
Authors’ original file for figure 412957_2011_938_MOESM4_ESM.tiff
Authors’ original file for figure 512957_2011_938_MOESM5_ESM.tiff
Petrylak DP, Tangen CM, Hussain MH, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004, 351: 1513-1520. 10.1056/NEJMoa041318. CrossRefPubMed
Petrigliano FA, Virk MS, Liu N, Sugiyama O, Yu D, Lieberman JR: Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen(PSCA) promoter. Prostatel. 2009, 69: 1422-1434. 10.1002/pros.20989. CrossRef
Nasu Y, Saika T, Ebara S, Kusaka N, Kaku H, Abarzua F, Manabe D, Thompson TC, Kumon H: Suicide gene therapy with adenoviral delivery of HSV-tk gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther. 2007, 15: 834-840. PubMed
Freytag SO, Stricker H, Pegg J, Paielli D, Pradhan DG, Peabody J, DePeralta-Venturina M, Xia X, Brown S, Lu M: Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed intermediate-to high-risk prostate cancer. Cancer Res. 2003, 63: 7497-7506. PubMed
Xu Q, Wang CH, Pack DW: Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers. Curr Pham Des. 2010, 16: 2350-2368. 10.2174/138161210791920469. CrossRef
Robe PA, Jolois O, N'Guyen M, Princen F, Malgrange B, Meville MP, Bours V: Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication. Int J Oncol. 2004, 25: 187-192. PubMed
Szatmári T, Huszty G, Désaknai S, Spasokoukotskaja T, Sasvári-Székely M, Staub M, Esik O, Sáfrány G, Lumniczky K: Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas. Cancer Gene Ther. 2008, 15: 154-164. 10.1038/sj.cgt.7701115. CrossRefPubMed
- In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II